节点文献
角膜胶原交联术治疗感染性角膜疾病研究进展
A review of corneal collagen cross-linking for the treatment of infectious corneal disease
【摘要】 角膜胶原交联术(CXL)利用紫外光A和感光剂核黄素,介导角膜基质内胶原纤维相互交联,提高角膜机械硬度和角膜基质的生物力学稳定性,从而阻止圆锥角膜等扩张性疾病的进展。近年来,经过临床研究发现,CXL对感染性角膜疾病的治疗也能取得良好的治疗效果,因此CXL成为了一种安全、有效的治疗感染性角膜疾病的新方法。综述该技术在治疗感染性角膜疾病方面的研究进展,回顾分析了该技术的基本原理,治疗感染性角膜疾病的作用机制、适应证、禁忌证、治疗技术的研究。
【Abstract】 Corneal collagen crosslinking(CXL)using ultraviolet light(UVA)-riboflavin photochemistry increases corneal rigidity and improves biomechanical stability of the stroma,thereby limiting the progression of corneal expansion. In recent years,CXL has also been used as a safe and effective treatment for infectious corneal diseases. In this paper,we review the basic principles,indications,and contraindication of CXL for the treatment of infectious corneal disease.
【关键词】 角膜胶原交联术;
感染性角膜疾病;
适应证;
禁忌证;
【Key words】 Corneal collagen cross linking; Infectious corneal disease; Indications; Contraindication;
【Key words】 Corneal collagen cross linking; Infectious corneal disease; Indications; Contraindication;
- 【文献出处】 山东大学耳鼻喉眼学报 ,Journal of Otolaryngology and Ophthalmology of Shandong University , 编辑部邮箱 ,2019年05期
- 【分类号】R779.6
- 【被引频次】1
- 【下载频次】116